Research & Development

Poor healthcare policies and infrastructure, but India’s pharma market continues to boom

IndiaIndia has numerous healthcare problems, ranging from inadequate policy monitoring to the widespread lack of health insurance, but a potentially huge, unsaturated market will see the country’s pharmaceutical industry continue to expand rapidly in the coming years, predicts the latest study by GlobalData.

Breast cancer treatments must adapt for elderly patients

Breast cancer_ribbonThe report* shows that despite many pharmacological treatment options being available for breast cancer treatment, including chemotherapy, hormonal therapy and targeted therapy, patients still fear relapses or resistant tumours.

European Medicines Agency recommends limiting long-term use of calcitonin medicines

CalcitoninThe European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that calcitonin-containing medicines should only be used for short-term treatment, because of evidence that long-term use of these medicines is associated with an increased risk of cancer.

Barriers to overcome in lupus drug development



There are four main types of lupus: neonatal, discoid (DLE), drug-induced (DIL) and systemic lupus erythmatosus (SLE). When lupus is discussed, most often times it is in reference to SLE as it affects the majority of patients.

Lupus is a chronic autoimmune disease that presents in masquerading ways thus making for difficult and precise diagnosis. 

Need for breakthrough renal disease treatments

Need-for-breakthrough-renal-disease-treatmentsThe rising incidence of kidney disease due to increasing obesity, high blood pressure and diabetes is forming a gigantic market for new renal disease treatments, according to a new report by GlobalData.

Would you like to receive our FREE e-newsletter?

* indicates required